{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:58:17Z","timestamp":1778803097709,"version":"3.51.4"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41401-020-0373-y","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:03:00Z","timestamp":1583413380000},"page":"464-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Psychosis in Parkinson\u2019s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges"],"prefix":"10.1038","volume":"41","author":[{"given":"John L.","family":"Waddington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"373_CR1","first-page":"1061","volume":"30","author":"B Ravina","year":"2015","unstructured":"Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, et al. Diagnostic criteria for psychosis in Parkinson\u2019s disease: report of an NINDS, NIMH work group. Mov Disord. 2015;30:1061\u20138.","journal-title":"Mov Disord"},{"key":"373_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","volume":"13","author":"DH ffytche","year":"2017","unstructured":"ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, et al. The psychosis spectrum in Parkinson disease. Nat Rev Neurol. 2017;13:81\u201395.","journal-title":"Nat Rev Neurol"},{"key":"373_CR3","volume-title":"An essay on the shaking palsy","author":"J Parkinson","year":"1817","unstructured":"Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely, and Jones; 1817."},{"key":"373_CR4","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/01.wnl.0000191325.31068.c4","volume":"66","author":"G Fenelon","year":"2006","unstructured":"Fenelon G, Goetz CG, Karenberg A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology. 2006;66:930\u201398.","journal-title":"Neurology"},{"key":"373_CR5","first-page":"115","volume":"65","author":"SA Factor","year":"1995","unstructured":"Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson\u2019s disease: drug-induced psychiatric states. Adv Neurol. 1995;65:115\u201338.","journal-title":"Adv Neurol"},{"key":"373_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0006-3223(99)00055-4","volume":"46","author":"JL Waddington","year":"1999","unstructured":"Waddington JL, Lane A, Larkin C, O\u2019Callaghan E. The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease. Biol Psychiatry. 1999;46:31\u20139.","journal-title":"Biol Psychiatry"},{"key":"373_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.26432","volume":"31","author":"J Pagonabarraga","year":"2016","unstructured":"Pagonabarraga J, Martinez-Horta S, Fernandez de Bobadilla R, Perez J, Ribosa-Nogue R, Marin J, et al. Minor hallucinations occur in drug-na\u00efve Parkinson\u2019s disease patients, even from the premotor phase. Mov Disord. 2016;31:45\u201352.","journal-title":"Mov Disord"},{"key":"373_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.parkreldis.2008.11.013","volume":"15","author":"CL Dotchin","year":"2009","unstructured":"Dotchin CL, Jusabani A, Walker RW. Non-motor symptoms in a prevalent population with Parkinson\u2019s disease in Tanzania. Parkinsonism Relat Disord. 2009;15:457\u201360.","journal-title":"Parkinsonism Relat Disord"},{"key":"373_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1176\/ajp.135.6.669","volume":"135","author":"C Moskovitz","year":"1978","unstructured":"Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry. 1978;135:669\u201375.","journal-title":"Am J Psychiatry"},{"key":"373_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2018.05.040","volume":"200","author":"MJ Cuesta","year":"2018","unstructured":"Cuesta MJ, Peralta V. Modeling neuromotor pathology in schizophrenia: a window to brain mechanisms and clinical insight into the syndrome. Schizophr Res. 2018;200:1\u20134.","journal-title":"Schizophr Res"},{"key":"373_CR11","unstructured":"Kraepelin E. Dementia praecox and paraphrenia, translated by Barclay RM. Edinburgh: Livingstone; 1919."},{"key":"373_CR12","unstructured":"Waddington JL, Crow TJ. Abnormal involuntary movements and psychosis in the preneuroleptic era and in unmedicated patients: implications for the concept of tardive dyskinesia. In: Wolf M, Mosnaim AD, editors. Tardive dyskinesia: biological mechanisms and clinical aspects. Washington, DC: American Psychiatric Press; 1988. p. 51\u201366."},{"key":"373_CR13","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1001\/jamapsychiatry.2016.1976","volume":"73","author":"KS Kendler","year":"2016","unstructured":"Kendler KS. Phenomenology of schizophrenia and the representativeness of modern diagnostic criteria. JAMA Psychiatry. 2016;73:1082\u201392.","journal-title":"JAMA Psychiatry"},{"key":"373_CR14","first-page":"87","volume":"5","author":"MH Lader","year":"1970","unstructured":"Lader MH. Drug-induced extrapyramidal syndromes. J R Coll Phys Lond. 1970;5:87\u201398.","journal-title":"J R Coll Phys Lond"},{"key":"373_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/S003329170003960X","volume":"10","author":"CD Marsden","year":"1980","unstructured":"Marsden CD, Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med. 1980;10:55\u201372.","journal-title":"Psychol Med"},{"key":"373_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0920-9964(91)90029-Q","volume":"4","author":"DE Casey","year":"1991","unstructured":"Casey DE. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia. Schizophr Res. 1991;4:109\u201320.","journal-title":"Schizophr Res"},{"key":"373_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373:31\u201341.","journal-title":"Lancet"},{"key":"373_CR18","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382:951\u201362.","journal-title":"Lancet"},{"key":"373_CR19","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1017\/S0033291708004716","volume":"39","author":"S Pappa","year":"2009","unstructured":"Pappa S, Dazzan P. Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychol Med. 2009;39:1065\u201376.","journal-title":"Psychol Med"},{"key":"373_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/schbul\/sbn126","volume":"35","author":"PF Whitty","year":"2009","unstructured":"Whitty PF, Owoeye O, Waddington JL. Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull. 2009;35:415\u201324.","journal-title":"Schizophr Bull"},{"key":"373_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/schbul\/sbn146","volume":"36","author":"JPF Koning","year":"2010","unstructured":"Koning JPF, Tenback DE, van Os J, Aleman A, Kahn RS, van Harten PN. Dyskinesia and parkinsonism in antipsychotic-na\u00efve patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophr Bull. 2010;36:723\u201331.","journal-title":"Schizophr Bull"},{"key":"373_CR22","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/mds.23050","volume":"25","author":"V Peralta","year":"2010","unstructured":"Peralta V, Campos MS, De Jalon EG, Cuesta MJ. Motor behaviour abnormalities in drug-na\u00efve patients with schizophrenia spectrum disorders. Mov Disord. 2010;25:1068\u201376.","journal-title":"Mov Disord"},{"key":"373_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-014-0280-1","volume":"14","author":"M Ayehu","year":"2014","unstructured":"Ayehu M, Shibre T, Milkias B, Fekadu A. Movement disorders in neuroleptic-na\u00efve patients with schizophrenia spectrum disorders. BMC Psychiatry. 2014;14:280.","journal-title":"BMC Psychiatry"},{"key":"373_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fpsyt.2018.00172","volume":"9","author":"A Ojagbemi","year":"2018","unstructured":"Ojagbemi A, Chiliza B, Bello T, Asmal L, Esan O, Emsley R, et al. Neurological soft signs, spontaneous and treatment emergent extrapyramidal syndromes in black Africans with first episode schizophrenia. Front Psychiatry. 2018;9:172.","journal-title":"Front Psychiatry"},{"key":"373_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.schres.2017.08.022","volume":"200","author":"JL Waddington","year":"2018","unstructured":"Waddington JL, O\u2019Tuathaigh CM. Modelling the neuromotor abnormalities of psychotic illness: putative mechanisms and systems dysfunction. Schizophr Res. 2018;200:12\u20139.","journal-title":"Schizophr Res"},{"key":"373_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386:896\u2013912.","journal-title":"Lancet"},{"key":"373_CR27","doi-asserted-by":"crossref","unstructured":"Waddington JL, Hennessy RJ, O'Tuathaigh CMP, Owoeye O, Russell V. Schizophrenia and the lifetime trajectory of psychotic illness:developmental neuroscience and pathobiology, redux. In: Brown AS, Patterson PH, editors. The origins of schizophrenia. New York: Columbia University Press; 2012. p. 3\u201321.","DOI":"10.7312\/brow15124-002"},{"key":"373_CR28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/schbul\/sbx118","volume":"43","author":"DR Weinberger","year":"2017","unstructured":"Weinberger DR. Future of days past: neurodevelopment and schizophrenia. Schizophr Bull. 2017;43:1164\u20138.","journal-title":"Schizophr Bull"},{"key":"373_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(06)70411-2","volume":"5","author":"A Schrag","year":"2006","unstructured":"Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol. 2006;5:355\u201363.","journal-title":"Lancet Neurol"},{"key":"373_CR30","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.parkreldis.2015.10.017","volume":"21","author":"S-Y Liu","year":"2015","unstructured":"Liu SY, Wu JJ, Zhao J, Huang SF, Wang YX, Ge JJ, et al. Onset-related subtypes of Parkinson\u2019s disease differ in the patterns of striatal dopaminergic dysfunction: a positron emission tomography study. Parkinsonism Relat Disord. 2015;21:1448\u201353.","journal-title":"Parkinsonism Relat Disord"},{"key":"373_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1017\/S0033291712002796","volume":"44","author":"M Van der Werf","year":"2014","unstructured":"Van der Werf M, Hanssen M, Kohler S, Verkaaik M, Verhey FR, RISE Investigators, et al. Systematic review and collaborative recalculation of 133693 incident cases of schizophrenia. Psychol Med. 2014;44:9\u201316.","journal-title":"Psychol Med"},{"key":"373_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.neubiorev.2017.08.024","volume":"83","author":"LV Van Assche","year":"2017","unstructured":"Van Assche LV, Morrens M, Luyten P, Van de Ven L, Vandenbulcke M. The neuropsychology and neurobiology of late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: a critical review. Neurosci Biobehav Rev. 2017;83:604\u201321.","journal-title":"Neurosci Biobehav Rev"},{"key":"373_CR33","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601.","journal-title":"Mov Disord"},{"key":"373_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1017\/S0033291700013763","volume":"6","author":"TJ Crow","year":"1976","unstructured":"Crow TJ, Johnstone EC, McClelland HA. The coincidence of schizophrenia and Parkinsonism: some neurochemical implications. Psychol Med. 1976;6:227\u201333.","journal-title":"Psychol Med"},{"key":"373_CR35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/schbul\/sbi025","volume":"31","author":"P Baldwin","year":"2005","unstructured":"Baldwin P, Browne D, Scully PJ, Quinn JF, Morgan MJ, Kinsella A, et al. Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan\/Monaghan study at 8 years. Schizophr Bull. 2005;31:624\u201338.","journal-title":"Schizophr Bull"},{"key":"373_CR36","doi-asserted-by":"publisher","unstructured":"Nkire N, Scully PJ, Browne DJ, Baldwin PA, Kingston T, Owoeye O, et al. Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Psychol Med. 2019. https:\/\/doi.org\/10.1017\/S0033291719003520.","DOI":"10.1017\/S0033291719003520"},{"key":"373_CR37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/cns.12973","volume":"24","author":"EM Joyce","year":"2018","unstructured":"Joyce EM. Organic psychosis: the pathobiology and treatment of delusions. CNS Neurosci Ther. 2018;24:598\u2013603.","journal-title":"CNS Neurosci Ther"},{"key":"373_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cger.2019.09.004","volume":"36","author":"KJ Lizarraga","year":"2020","unstructured":"Lizarraga KJ, Fox SH, Strafella AP, Lang AE. Hallucinations, delusions and impulse control disorders in Parkinson disease. Clin Geriatr Med. 2020;36:105\u201318.","journal-title":"Clin Geriatr Med"},{"key":"373_CR39","doi-asserted-by":"crossref","unstructured":"Arango C, Carpenter WT. The schizophrenia construct: symptomatic presentation. In: Weinberger DR, Harrison PJ, editors. Schizophrenia. Oxford: Wiley-Blackwell; 2011. p. 9\u201323.","DOI":"10.1002\/9781444327298.ch2"},{"key":"373_CR40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.psychres.2017.01.102","volume":"252","author":"S McCarthy-Jones","year":"2017","unstructured":"McCarthy-Jones S, Smailes D, Corvin A, Gill M, Morris DW, Dinan TG, et al. Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum disorders. Psychiat Res. 2017;252:154\u201360.","journal-title":"Psychiat Res"},{"key":"373_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/schbul\/sbw132","volume":"43","author":"F Waters","year":"2017","unstructured":"Waters F, Fernyhough C. Hallucinations: a systematic review of points of similarity and difference across diagnostic classes. Schizophr Bull. 2017;43:32\u201343.","journal-title":"Schizophr Bull"},{"key":"373_CR42","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1017\/S0033291718003161","volume":"49","author":"CL Eversfield","year":"2018","unstructured":"Eversfield CL, Orton LD. Auditory and visual hallucination prevalence in Parkinson\u2019s disease and dementia with Lewy bodies: a systematic review and meta-analysis. Psychol Med. 2018;49:2342\u201353.","journal-title":"Psychol Med"},{"key":"373_CR43","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/mds.22839","volume":"25","author":"G Fenelon","year":"2010","unstructured":"Fenelon G, Soulas T, Zenasni F, de Langavant LC. The changing face of Parkinson\u2019s disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov Disord. 2010;25:763\u20136.","journal-title":"Mov Disord"},{"key":"373_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/JGP.0b013e31821f1b41","volume":"20","author":"J Mack","year":"2012","unstructured":"Mack J, Rabins P, Anderson K, Goldstein S, Grill S, Hirsch ES, et al. Prevalence of psychotic symptoms in a community-based Parkinson disease sample. Am J Geriatr Psychiatry. 2012;20:123\u201332.","journal-title":"Am J Geriatr Psychiatry"},{"key":"373_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jns.2017.01.014","volume":"374","author":"K Frei","year":"2017","unstructured":"Frei K, Truong DD. Hallucinations and the spectrum of psychosis in Parkinson\u2019s disease. J Neurol Sci. 2017;374:56\u201362.","journal-title":"J Neurol Sci"},{"key":"373_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11065-018-9379-3","volume":"28","author":"N Warren","year":"2018","unstructured":"Warren N, O\u2019Gorman C, Hume Z, Kisely S, Siskind D. Delusions in Parkinson\u2019s disease: a systematic review of published cases. Neuropsychol Rev. 2018;28:310\u20136.","journal-title":"Neuropsychol Rev"},{"key":"373_CR47","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/mds.27665","volume":"34","author":"Y Guo","year":"2019","unstructured":"Guo Y, Xu W, Liu FT, Li JQ, Cao XP, Tan L, et al. Modifiable risk factors for cognitive impairment in Parkinson\u2019s disease: a systematic review and meta-analysis of prospective cohort studies. Mov Disord. 2019;34:876\u201383.","journal-title":"Mov Disord"},{"key":"373_CR48","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/schbul\/sbt125","volume":"40","author":"MJ Cuesta","year":"2014","unstructured":"Cuesta MJ, Sanchez-Torres AM, de Jalon EG, Campos MS, Ibanez B, Moreno-Izco L, et al. Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-na\u00efve patients with first-episode psychosis: a 6-month follow-up study. Schizophr Bull. 2014;40:1164\u201373.","journal-title":"Schizophr Bull"},{"key":"373_CR49","doi-asserted-by":"publisher","first-page":"eaap8757.","DOI":"10.1126\/science.aap8757.","volume":"360","author":"Brainstorm Consortium.","year":"2018","unstructured":"Brainstorm Consortium. Analysis of shared heritability in common disorders of the brain. Science. 2018;360:eaap8757. https:\/\/doi.org\/10.1126\/science.aap8757.","journal-title":"Science"},{"key":"373_CR50","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1474-4422(16)00071-5","volume":"15","author":"KY Mok","year":"2016","unstructured":"Mok KY, Sheerin U, Simon-Sanchez J, Salaka A, Chester L, Escott-Price V, et al. Deletions at 22q11.2 in idiopathic Parkinson\u2019s disease: a combined analysis of genome-wide association data. Lancet Neurol. 2016;15:585\u201396.","journal-title":"Lancet Neurol"},{"key":"373_CR51","doi-asserted-by":"publisher","first-page":"e2059","DOI":"10.1212\/WNL.0000000000005660","volume":"90","author":"E Boot","year":"2018","unstructured":"Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, et al. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology. 2018;90:e2059\u201367.","journal-title":"Neurology"},{"key":"373_CR52","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","volume":"171","author":"M Schneider","year":"2014","unstructured":"Schneider M, Debbane M, Bassett AS, Chow EW, Fung WL, van den Bree M, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 2014;171:627\u201339.","journal-title":"Am J Psychiatry"},{"key":"373_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2015.09.007","volume":"59","author":"CP Weingarten","year":"2015","unstructured":"Weingarten CP, Sundman MH, Hickey P, Chen NK. Neuroimaging of Parkinson\u2019s disease: expanding views. Neurosci Biobehav Rev. 2015;59:16\u201352.","journal-title":"Neurosci Biobehav Rev"},{"key":"373_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/schbul\/sbr111","volume":"39","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in schizophrenia, Part 1: meta-analysis of dopamine active transporter (DAT) density. Schizophr Bull. 2013;39:22\u201332.","journal-title":"Schizophr Bull"},{"key":"373_CR55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tins.2018.12.004","volume":"42","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon RA, Abi-Dargham A, Howes OD. Schizophrenia, dopamine and the striatum: from biology to symptoms. Trends Neurosci. 2019;42:205\u201320.","journal-title":"Trends Neurosci"},{"key":"373_CR56","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.eplepsyres.2009.03.018","volume":"85","author":"B Elliott","year":"2009","unstructured":"Elliott B, Joyce E, Shorvon S. Delusions, illusions and hallucinations in epilepsy: 1. Elementary phenomena. Epilepsy Res. 2009;85:162\u201371.","journal-title":"Epilepsy Res"},{"key":"373_CR57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.eplepsyres.2009.03.017","volume":"85","author":"B Elliott","year":"2009","unstructured":"Elliott B, Joyce E, Shorvon S. Delusions, illusions and hallucinations in epilepsy: 2. Complex phenomena and psychosis. Epilepsy Res. 2009;85:172\u201386.","journal-title":"Epilepsy Res"},{"key":"373_CR58","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301\u20138.","journal-title":"Am J Psychiatry"},{"key":"373_CR59","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00002826-199408000-00008","volume":"17","author":"RB Rosse","year":"1994","unstructured":"Rosse RB, Collins JP, Fay-McCarthy M, Alim TN, Wyatt RJ, Deutsch SI. Phenomenological comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study. Clin Neuropharmacol. 1994;17:359\u201369.","journal-title":"Clin Neuropharmacol"},{"key":"373_CR60","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/ajmg.b.32177","volume":"162B","author":"RM Murray","year":"2013","unstructured":"Murray RM, Paparelli A, Morrison PD, Marconi A, Di Forti M. What can we learn about schizophrenia from studying the human model, drug-induced psychosis? Am J Med Genet Neuropsychiatr Genet. 2013;162B:661\u201370.","journal-title":"Am J Med Genet Neuropsychiatr Genet"},{"key":"373_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/schbul\/2.1.19","volume":"2","author":"HY Meltzer","year":"1976","unstructured":"Meltzer HY, Stahl SM. The dopamine hypothesis of schizophrenia: a review. Schizophr Bull. 1976;2:19\u201376.","journal-title":"Schizophr Bull"},{"key":"373_CR62","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/schbul\/sbx180","volume":"44","author":"RA McCutcheon","year":"2018","unstructured":"McCutcheon RA, Beck K, Jauhar S, Howes OD. Defining the locus of dopaminergic dysfunction in schizophrenia: a meta-analysis and test of the mesolimbic hypothesis. Schizophr Bull. 2018;44:1301\u201311.","journal-title":"Schizophr Bull"},{"key":"373_CR63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","volume":"9","author":"GE Alexander","year":"1986","unstructured":"Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357\u201381.","journal-title":"Annu Rev Neurosci"},{"key":"373_CR64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamapsychiatry.2014.2206","volume":"72","author":"M Goodkind","year":"2015","unstructured":"Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry. 2015;72:305\u201315.","journal-title":"JAMA Psychiatry"},{"key":"373_CR65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamapsychiatry.2014.1734","volume":"72","author":"DK Sarpal","year":"2015","unstructured":"Sarpal DK, Robinson DG, Lencz T, Argyelan M, Ikuta T, Karlsgodt K, et al. Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia. JAMA Psychiatry. 2015;72:5\u201313.","journal-title":"JAMA Psychiatry"},{"key":"373_CR66","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/schbul\/sbv228","volume":"42","author":"NV Kraguljac","year":"2016","unstructured":"Kraguljac NV, White DM, Hadley N, Hadley JA, Ver Hoef L, Davis E, et al. Abberant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: a longitudinal resting state functional MRI study. Schizophr Bull. 2016;42:1046\u201355.","journal-title":"Schizophr Bull"},{"key":"373_CR67","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jamapsychiatry.2017.0669","volume":"74","author":"JM Sheffield","year":"2017","unstructured":"Sheffield JM, Kandala S, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA, et al. Transdiagnostic associations between functional brain network integrity and cognition. JAMA Psychiatry. 2017;74:605\u201313.","journal-title":"JAMA Psychiatry"},{"key":"373_CR68","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nbd.2007.09.004","volume":"29","author":"RY Moore","year":"2008","unstructured":"Moore RY, Whone AL, Brooks DJ. Extrastriatal monoamine neuron function in Parkinson\u2019s disease: an 18F-dopa PET study. Neurobiol Dis. 2008;29:381\u201390.","journal-title":"Neurobiol Dis"},{"key":"373_CR69","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/bs.irn.2018.07.027","volume":"141","author":"NI Bohnen","year":"2018","unstructured":"Bohnen NI, Kane P, Muller MLMT. Molecular imaging of the cholinergic system in Parkinson\u2019s disease. Int Rev Neurobiol. 2018;141:211\u201350.","journal-title":"Int Rev Neurobiol"},{"key":"373_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.parkreldis.2019.02.017","volume":"63","author":"R Morris","year":"2019","unstructured":"Morris R, Martini DN, Madhyastha T, Kelly VE, Grabowski TJ, Nutt J, et al. Overview of the cholinergic contribution to gait, balance and falls in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2019;63:20\u201330.","journal-title":"Parkinsonism Relat Disord"},{"key":"373_CR71","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s00259-019-04324-5","volume":"46","author":"A Pilotto","year":"2019","unstructured":"Pilotto A, di Cola FS, Premi E, Grasso R, Turrone R, Gipponi S, et al. Extrastriatal dopaminergic and serotonergic pathways in Parkinson\u2019s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. Eur J Nuc Med Mol Imaging. 2019;46:1642\u201351.","journal-title":"Eur J Nuc Med Mol Imaging"},{"key":"373_CR72","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18:435\u201350.","journal-title":"Nat Rev Neurosci"},{"key":"373_CR73","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/ene.13390","volume":"24","author":"E Jaakkola","year":"2017","unstructured":"Jaakkola E, Jousta J, Makinen E, Johansson J, Kaasinen V. Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson\u2019s disease. Eur J Neurol. 2017;24:1341\u20137.","journal-title":"Eur J Neurol"},{"issue":"Suppl 3","key":"373_CR74","doi-asserted-by":"publisher","first-page":"S548","DOI":"10.1002\/mds.22062","volume":"23","author":"JA Obeso","year":"2008","unstructured":"Obeso JA, Rodriguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, et al. Functional organization of the basal ganglia: therapeutic implications for Parkinson\u2019s disease. Mov Disord. 2008;23(Suppl 3):S548\u201359.","journal-title":"Mov Disord"},{"key":"373_CR75","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.neuroimage.2011.12.021","volume":"62","author":"KL Poston","year":"2012","unstructured":"Poston KL, Eidelberg D. Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage. 2012;62:2261\u201370.","journal-title":"Neuroimage"},{"key":"373_CR76","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.pscychresns.2015.06.010","volume":"233","author":"S Walther","year":"2015","unstructured":"Walther S. Psychomotor symptoms of schizophrenia map on the cerebral motor circuit. Psychiat Res. 2015;233:293\u20138.","journal-title":"Psychiat Res"},{"key":"373_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.05.006","volume":"74","author":"JK Seamans","year":"2004","unstructured":"Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 2004;74:1\u201358.","journal-title":"Prog Neurobiol"},{"key":"373_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.eclinm.2019.01.012","volume":"8","author":"CPE Rollins","year":"2019","unstructured":"Rollins CPE, Garrison JR, Simons JS, Rowe JB, O\u2019Callaghan C, Murray GK, et al. Meta-analytic evidence for the plurality of mechanisms in transdiagnostic structural MRI studies of hallucination status. EClinical Med. 2019;8:57\u201371.","journal-title":"EClinical Med"},{"key":"373_CR79","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.schres.2017.04.016","volume":"194","author":"JY Khokhar","year":"2018","unstructured":"Khokhar JY, Dwiel LL, Henricks AM, Doucette WT, Green AI. The link between schizophrenia and substance use disorder: a unifying hypothesis. Schizophr Res. 2018;194:78\u201385.","journal-title":"Schizophr Res"},{"key":"373_CR80","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/jnnp-2017-317102","volume":"89","author":"J Allebone","year":"2018","unstructured":"Allebone J, Kanaan R, Wilson SJ. Systematic review of structural and functional brain alterations in psychosis of epilepsy. J Neurol Neurosurg Psychiatry. 2018;89:611\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"373_CR81","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/schbul\/sby154","volume":"45","author":"A Heinz","year":"2019","unstructured":"Heinz A, Murray GK, Schlagenhauf F, Sterzer P, Grace AA, Waltz JA. Towards a unifying cognitive, neurophysiological and computational neuroscience account of schizophrenia. Schizophr Bull. 2019;45:1092\u2013100.","journal-title":"Schizophr Bull"},{"key":"373_CR82","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1176\/ajp.150.1.146","volume":"150","author":"P Buckley","year":"1993","unstructured":"Buckley P, Stack JP, Madigan C, O\u2019Callaghan E, Larkin C, Redmond O, et al. Magnetic resonance imaging of schizophrenia-like psychoses associated with cerebral trauma: clinicopathological correlates. Am J Psychiatry. 1993;150:146\u20138.","journal-title":"Am J Psychiatry"},{"key":"373_CR83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.msard.2016.12.012","volume":"12","author":"CR Camara-Lemarroy","year":"2017","unstructured":"Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, Berrrios-Morales I, Ionete C, Riskind P. The varieties of psychosis in multiple sclerosis: a systematic review of cases. Mult Scler Relat Disord. 2017;12:9\u201314.","journal-title":"Mult Scler Relat Disord"},{"key":"373_CR84","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/jnnp.69.2.167","volume":"69","author":"MS Mega","year":"2000","unstructured":"Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL. Cerebral correlates of psychotic symptoms in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2000;69:167\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"373_CR85","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.biopsych.2013.08.020","volume":"75","author":"PS Murray","year":"2014","unstructured":"Murray PS, Kumar S, Demichele-Sweet MA, Sweet RA. Psychosis in Alzheimer\u2019s disease. Biol Psychiatry. 2014;75:542\u201352.","journal-title":"Biol Psychiatry"},{"key":"373_CR86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0920-9964(95)00064-X","volume":"18","author":"JL Waddington","year":"1995","unstructured":"Waddington JL, Youssef HA, Farrell MA, Toland J. Initial \u2018schizophrenia-like\u2019 psychosis in Pick\u2019s disease: case study with neuroimaging and neuropathology, and implications for frontotemporal dysfunction in schizophrenia. Schizophr Res. 1995;18:79\u201382.","journal-title":"Schizophr Res"},{"key":"373_CR87","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.biopsych.2015.03.028","volume":"78","author":"D Galimberti","year":"2015","unstructured":"Galimberti D, Dell\u2019Osso B, Altamura AC, Scarpini E. Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis. Biol Psychiatry. 2015;78:684\u201392.","journal-title":"Biol Psychiatry"},{"key":"373_CR88","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fneur.2018.00930","volume":"9","author":"NP Rocha","year":"2018","unstructured":"Rocha NP, Mwangi B, Gutierrez-Candano CA, Sampaio C, Furr Stimming E, Teixeira AL. The clinical picture of psychosis in manifest Huntington\u2019s disease: A comprehensive analysis of the Enroll-HD database. Front Neurol. 2018;9:930.","journal-title":"Front Neurol"},{"key":"373_CR89","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5498\/wjp.v5.i3.273","volume":"5","author":"S Madhusoodanan","year":"2015","unstructured":"Madhusoodanan S, Sting MB, Farah T, Ugur U. Psychiatric aspects of brain tumors: a review. World J Psychiatry. 2015;5:273\u201385.","journal-title":"World J Psychiatry"},{"key":"373_CR90","first-page":"240","volume":"34","author":"R Upthegrove","year":"2017","unstructured":"Upthegrove R, Marwaha S, Birchwood M. Depression and schizophrenia: cause, consequence or trans-diagnostic issue? Schizophr Bull. 2017;34:240\u20134.","journal-title":"Schizophr Bull"},{"key":"373_CR91","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/schbul\/sby166","volume":"45","author":"PC Tu","year":"2019","unstructured":"Tu PC, Bai YM, Li CT, Chen MH, Lin WC, Chang WC, et al. Identification of common thalamocortical dysconnectivity in four major psychiatric disorders. Schizophr Bull. 2019;45:1143\u201351.","journal-title":"Schizophr Bull"},{"key":"373_CR92","doi-asserted-by":"publisher","unstructured":"Ma Q, Tang Y, Wang F, Liao X, Jiang X, Wei S, et al. Transdiagnostic dysfunctions in brain modules across patients with schizophrenia, bipolar disorder, and major depressive disorder: a connectome-based study. Schizophr Bull 2019. https:\/\/doi.org\/10.1093\/schbul\/sbz111.","DOI":"10.1093\/schbul\/sbz111"},{"key":"373_CR93","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pnpbp.2018.05.025","volume":"86","author":"S Wang","year":"2018","unstructured":"Wang S, Mao S, Xiang D, Fang C. Association between depression and the subsequent risk of Parkinson\u2019s disease: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:186\u201392.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"373_CR94","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamapsychiatry.2013.269","volume":"70","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rossler A, Schultze-Lutter F, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013;70:107\u201320.","journal-title":"JAMA Psychiatry"},{"key":"373_CR95","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/wps.20310","volume":"15","author":"J van Os","year":"2016","unstructured":"van Os J, Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry. 2016;15:118\u201324.","journal-title":"World Psychiatry"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0373-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0373-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0373-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:03Z","timestamp":1684616583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0373-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["373"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-0373-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"17 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}